Jeong-woo Cho (SK Biopharmaceuticals)
SK Biopharmaceuticals emerges from pandemic with pitch for $822M IPO
The lively biotech IPO streak isn’t confined in the US — or even Hong Kong for that matter.
On Monday, SK Biopharmaceuticals revealed that it’s eyeing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
